Long-Term Outcomes of Nonoperative and Surgical Management of Paget-Schroetter Syndrome
Open Access
- 8 September 2022
- journal article
- research article
- Published by SAGE Publications in Journal of Endovascular Therapy
- Vol. 31 (2) , 171-177
Abstract
Purpose: In Paget-Schroetter Syndrome (PSS), subclavian vein thrombosis is caused by external compression of the subclavian vein at the costoclavicular junction. Paget-Schroetter Syndrome can be treated nonoperatively, surgically, or with a combination of treatments. Nonoperative management consists, in most cases, of anticoagulation (AC) or catheter-directed thrombolysis (CDT). With surgical management, decompression of the subclavian vein is performed by resection of the first rib. No prospective randomized trials are available to determine whether nonoperative or surgical management is superior. We report our long-term outcomes of both nonoperative and surgically treated patients. Materials and Methods: We retrospectively analyzed all patients with PSS who were treated between January 1990 and December 2015. Patients were divided based on primary nonoperative or primary surgical therapy. Long-term outcomes regarding functional outcomes were assessed by questionnaires using the “Disability of the Arm, Shoulder, and Hand” (DASH) questionnaire, a modified Villalta score, and a disease-specific question regarding lifestyle changes. Results: In total, 91 patients (95 limbs) were included. Seventy patients (73 limbs) were treated nonoperatively and 21 patients (22 limbs) surgically. Questionnaires were returned by 67 patients (70 limbs). The mean follow-up was 184 months (range, 43–459 months). All functional outcomes were better in the surgical group compared with the nonoperatively treated group (DASH general 3.11 vs 9.86; DASH work 0.35 vs 11.47; DASH sport 5.85 vs 17.98, and modified Villalta score 1.11 vs 3.20 points). Surgically treated patients were more likely to be able to continue their original lifestyle and sports activities (84% vs 40%, p=0.005). Patients with recurrence of thrombosis or the need for surgical intervention after primary nonoperative management reported worse functional outcomes. Conclusion: Surgical management of PSS with immediate CDT followed by first rib resection leads to excellent functional outcomes with low risk of complications. The results of nonoperative management in our non-matched retrospective comparative series were satisfactory, but resulted in worse functional outcomes and more patients needing to adjust their lifestyle compared with surgically treated patients. Clinical Impact: Patients with Paget-Schroetter Syndrome and their attending physicians are burdened by the lack of evidence concerning the optimal treatment of this entity. Case series comparing the outcomes of non-operative treatment with surgical treatment are scarce and often not focussed on functional outcomes. Data from this series can aid in the shared decision making after diagnosis of Paget-Schroetter Syndrome. Functional outcomes of non-operative management can be satisfying although high demand patient who are not willing to alter their daily activities are probably better off with surgical management.Keywords
This publication has 12 references indexed in Scilit:
- Lack of association between venous hemodynamics, venous morphology and the postthrombotic syndrome after upper extremity deep venous thrombosisPhlebology: The Journal of Venous Disease, 2013
- The DASH and the QuickDASH instruments. Normative values in the general population in NorwayJournal of Hand Surgery (European Volume), 2013
- Effort thrombosis (Paget-Schroetter syndrome) in active young adults: Current concepts in diagnosis and treatmentJournal of Vascular Nursing, 2006
- Long-term thrombotic recurrence after nonoperative management of Paget-Schroetter syndromeJournal of Vascular Surgery, 2006
- Reliable change and minimum important difference (MID) proportions facilitated group responsiveness comparisons using individual threshold criteriaJournal of Clinical Epidemiology, 2004
- Outcome after thrombolysis and selective thoracic outlet decompression for primary axillary vein thrombosisJournal of Vascular Surgery, 2001
- Long-Term Sequelae of Spontaneous Axillary–Subclavian Venous ThrombosisAnnals of Internal Medicine, 1999
- Development of an upper extremity outcome measure: The DASH (disabilities of the arm, shoulder, and head)American Journal of Industrial Medicine, 1996
- Evaluation of a new treatment strategy for Paget-Schroetter syndrome: Spontaneous thrombosis of the axillary-subclavian veinJournal of Vascular Surgery, 1993
- Effort thrombosis: Role of interventional therapyCardioVascular and Interventional Radiology, 1990